Gene: SYTL2
Official Full Name: synaptotagmin like 2provided by HGNC
Gene Summary: The protein encoded by this gene is a synaptotagmin-like protein (SLP) that belongs to a C2 domain-containing protein family. The SLP homology domain (SHD) of this protein has been shown to specifically bind the GTP-bound form of Ras-related protein Rab-27A (RAB27A). This protein plays a role in RAB27A-dependent vesicle trafficking and controls melanosome distribution in the cell periphery. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13604 | SYTL2 Knockout cell line (HCT 116) | Human | SYTL2 | 1:2~1:4 | Negative | Online Inquiry |
KO13605 | SYTL2 Knockout cell line (A549) | Human | SYTL2 | 1:3~1:4 | Negative | Online Inquiry |
SYTL2 Gene Knockout Cell Lines represent an innovative biotechnological product designed to facilitate research into the function of the SYTL2 gene, which is implicated in various cellular processes, including intracellular transport and neuronal signaling. These cell lines have been genetically modified to create specific deletions in the SYTL2 gene, allowing for the study of its role in biological pathways and disease mechanisms.
The primary function of these knockout cell lines is to enable researchers to investigate the phenotypic and molecular consequences of SYTL2 gene loss. By employing CRISPR/Cas9 genome editing technology, researchers can study the resulting alterations in cellular behavior, protein interactions, and signaling cascades. This level of precision provides insights into the gene's role in both normal physiology and pathological conditions, including cancer and neurodegenerative diseases.
The scientific importance of SYTL2 Gene Knockout Cell Lines is evident in their applications across various research domains. In preclinical studies, these models provide critical information that supports drug discovery efforts and elucidates mechanisms of action for therapies targeting associated pathways. Consequently, they serve as essential tools in both academic and clinical research settings, paving the way for advancements in personalized medicine and targeted therapies.
One of the unique selling points of SYTL2 Gene Knockout Cell Lines is their high specificity and reproducibility compared to traditional knockdown methods such as RNA interference, which can lead to off-target effects. Additionally, our cell lines are derived from well-characterized cellular backgrounds, ensuring compatibility with a wide range of experimental conditions.
For researchers and clinicians, the value of using SYTL2 Gene Knockout Cell Lines lies in their ability to generate robust and reliable data that enhances the understanding of biological processes and aids in the development of novel therapeutic strategies. Our commitment to quality and precision is backed by years of expertise in the field of genetic engineering, establishing us as a trusted provider of biological products that empower scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.